Skip to main content
Carlos Vigil Gonzales, MD, Hematology, Chicago, IL

Carlos Enrique Vigil Gonzales MD FACP

Hematologic Oncology


Physician

Join to View Full Profile
  • 676 N Saint Clair StSte 850Chicago, IL 60611

  • Phone+1 312-695-6180

  • Fax+1 312-695-6189

Dr. Vigil Gonzales is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Carlos Vigil Gonzales is a sub specialized malignant hematologist in Madison ,NJ .He received his medical degree from Cayetano Heredia University and has been in practice for more than 20 years. His main interest is clinical and translational research mainly in myeloid malignancies.

Clinical Expertise

  • Myelodysplastic syndromes , Stem cell transplantation, Leukemia, Myeloid leukemia

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Hematopoietic Stem Cell Transplant, 2014 - 2015
  •  M.D. Anderson Cancer Center
    M.D. Anderson Cancer CenterFellowship, Leukemia , 2009 - 2010
  • University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General Hospital
    University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2003 - 2006
  • Cayetano Heredia University
    Cayetano Heredia UniversityClass of 2000

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2026
  • IA State Medical License
    IA State Medical License 2015 - 2021
  • NY State Medical License
    NY State Medical License 2010 - 2013
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Addition of Crenolanib to Induction Chemotherapy Overcomes the Poor Prognostic Impact of Co- Occurring Driver Mutations in Patients with Newly Diagnosed FLT3-Mutated AML 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Other Languages

  • Spanish, French

Industry Relationships

  • Sr Clinical trial Physician, Bristol Myers Squibb

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: